, Volume 40, Issue 3, pp 770–777 | Cite as

TIPE2 Inhibits the Expression of Asthma-Related Inflammatory Factors in Hyperstretched Bronchial Epithelial Cells Through the Wnt/β-Catenin Pathway

  • Xinrong Sun
  • Lu Chen
  • Wen YanEmail author


Childhood asthma, an airway inflammatory disease, is a serious threat to the child’s quality of life. Recently, TIPE2 expression was reported to be decreased in children with asthma. Therefore, additional studies focusing on TIPE2 might provide an approach for treating childhood asthma. In this study, we found that TIPE2 was poorly expressed in hyperstretched human bronchial epithelial cells (BEAS-2B). TIPE2 overexpression also significantly suppressed the stretch-induced secretion of asthma-related inflammatory factors (TNF-α, TSLP, MMP-9, and VEGF). In contrast, TIPE2 inhibition significantly promoted the secretion of TNF-α, TSLP, MMP-9, and VEGF. Furthermore, overexpression of TIPE2 remarkably inhibited the activation of Wnt/β-catenin in hyperstretched BEAS-2B cells, while siTIPE2 activated Wnt/β-catenin in hyperstretched BEAS-2B cells. Further analysis showed that the Wnt/β-catenin signal inhibitor Dkk-1 could further enhance the TIPE2-induced suppression of Wnt/β-catenin signaling, which also suppressed the siTIPE2-induced secretion of TNF-α, TSLP, MMP-9, and VEGF in hyperstretched BEAS-2B cells. Dkk-1 reversed the effects of siRNA-TIPE2 on Wnt/β-catenin signaling and inflammatory cytokines. In summary, we have exhibited that TIPE2 inhibited the expression of asthma-related inflammatory factors in hyperstretched BEAS-2B cells by suppressing the Wnt/β-catenin signaling pathway. TIPE2 may be involved in airway inflammation during asthma attack, and it may be used as a potential therapeutic target for bronchial epithelial inflammation in childhood asthma.


childhood asthma TIPE2 bronchial epithelial cells inflammation Wnt/β-catenin 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no competing interests.


  1. 1.
    Mete, F., E. Ozkaya, S. Aras, V. Koksal, O. Etlik, and I. Baris. 2014. Association between gene polymorphisms in TIM1, TSLP, IL18R1 and childhood asthma in Turkish population. International Journal of Clinical and Experimental Medicine 7: 1071–1077.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Elias, J.A., C.G. Lee, T. Zheng, B. Ma, R.J. Homer, and Z. Zhu. 2003. New insights into the pathogenesis of asthma. Journal of Clinical Investigation 111: 291–297.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Haj-Salem, I., R. Fakhfakh, J.C. Berube, E. Jacques, S. Plante, M.J. Simard, Y. Bosse, and J. Chakir. 2015. MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFbetaR2 gene in severe asthma. Allergy 70: 212–219.CrossRefPubMedGoogle Scholar
  4. 4.
    Gras, D., P. Chanez, I. Vachier, A. Petit, and A. Bourdin. 2013. Bronchial epithelium as a target for innovative treatments in asthma. Pharmacology & Therapeutics 140: 290–305.CrossRefGoogle Scholar
  5. 5.
    Devries, A., and D. Vercelli. 2013. Epigenetics of human asthma and allergy: promises to keep. Asian Pacific Journal of Allergy and Immunology 31: 183–189.PubMedGoogle Scholar
  6. 6.
    Zhao, G., X. Lin, M. Zhou, and J. Zhao. 2013. Association between CC10 + 38A/G polymorphism and asthma risk: a meta-analysis. Pakistan Journal of Medical Sciences 29: 1439–1443.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Freundt, E.C., N. Bidere, and M.J. Lenardo. 2008. A different TIPE of immune homeostasis. Cell 133: 401–402.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Sun, H., S. Gong, R.J. Carmody, A. Hilliard, L. Li, J. Sun, L. Kong, L. Xu, B. Hilliard, S. Hu, H. Shen, X. Yang, and Y.H. Chen. 2008. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133: 415–426.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kong, L., K. Liu, Y.Z. Zhang, M. Jin, B.R. Wu, W.Z. Wang, W. Li, Y.M. Nan, and Y.H. Chen. 2013. Downregulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with chronic hepatitis C. Hepatology International 7: 844–849.CrossRefPubMedGoogle Scholar
  10. 10.
    Ma, Y., X. Liu, Z. Wei, X. Wang, Z. Wang, W. Zhong, Y. Li, F. Zhu, C. Guo, and L. Zhang. 2013. The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children. Scandinavian Journal of Immunology 78: 523–528.CrossRefPubMedGoogle Scholar
  11. 11.
    Sun, H., G. Zhuang, L. Chai, Z. Wang, D. Johnson, Y. Ma, and Y.H. Chen. 2012. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway. Journal of Immunology 189: 2768–2773.CrossRefGoogle Scholar
  12. 12.
    Zhang, G., C. Hao, Y. Lou, W. Xi, X. Wang, Y. Wang, Z. Qu, C. Guo, Y. Chen, Y. Zhang, and S. Liu. 2010. Tissue-specific expression of TIPE2 provides insights into its function. Molecular Immunology 47: 2435–2442.CrossRefPubMedGoogle Scholar
  13. 13.
    MacDonald, B.T., K. Tamai, and X. He. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell 17: 9–26.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Baron, R., and M. Kneissel. 2013. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nature Medicine 19: 179–192.CrossRefPubMedGoogle Scholar
  15. 15.
    Baarsma, H.A., M. Konigshoff, and R. Gosens. 2013. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets. Pharmacology & Therapeutics 138: 66–83.CrossRefGoogle Scholar
  16. 16.
    Clevers, H., and R. Nusse. 2012. Wnt/beta-catenin signaling and disease. Cell 149: 1192–1205.CrossRefPubMedGoogle Scholar
  17. 17.
    Le, P.N., J.D. McDermott, and A. Jimeno. 2015. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. Pharmacology & Therapeutics 146: 1–11.CrossRefGoogle Scholar
  18. 18.
    George, S.J. 2008. Wnt pathway: a new role in regulation of inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 400–402.CrossRefPubMedGoogle Scholar
  19. 19.
    Tan, R.J., D. Zhou, L. Zhou, and Y. Liu. 2014. Wnt/beta-catenin signaling and kidney fibrosis. Kidney International Supplement 4: 84–90.CrossRefGoogle Scholar
  20. 20.
    Guo, L., T. Wang, Y. Wu, Z. Yuan, J. Dong, X. Li, J. An, Z. Liao, X. Zhang, D. Xu, and F.Q. Wen. 2016. WNT/beta-catenin signaling regulates cigarette smoke-induced airway inflammation via the PPARdelta/p38 pathway. Laboratory Investigation; A Journal of Technical Methods and Pathology 96: 218–229.CrossRefPubMedGoogle Scholar
  21. 21.
    Kwak, H.J., D.W. Park, J.Y. Seo, J.Y. Moon, T.H. Kim, J.W. Sohn, D.H. Shin, H.J. Yoon, S.S. Park, and S.H. Kim. 2015. The Wnt/beta-catenin signaling pathway regulates the development of airway remodeling in patients with asthma. Experimental & Molecular Medicine 47: e198.CrossRefGoogle Scholar
  22. 22.
    Reuter, S., H. Martin, H. Beckert, M. Bros, E. Montermann, C. Belz, A. Heinz, S. Ohngemach, U. Sahin, M. Stassen, R. Buhl, L. Eshkind, and C. Taube. 2014. The Wnt/beta-catenin pathway attenuates experimental allergic airway disease. Journal of Immunology 193: 485–495.CrossRefGoogle Scholar
  23. 23.
    Bao, Z., S. Lim, W. Liao, Y. Lin, C. Thiemermann, B.P. Leung, and W.S. Wong. 2007. Glycogen synthase kinase-3beta inhibition attenuates asthma in mice. American Journal of Respiratory and Critical Care Medicine 176: 431–438.CrossRefPubMedGoogle Scholar
  24. 24.
    Fredberg, J.J. 2000. Frozen objects: small airways, big breaths, and asthma. The Journal of Allergy and Clinical Immunology 106: 615–624.CrossRefPubMedGoogle Scholar
  25. 25.
    Wang, J., L. Liu, Y. Xia, and D. Wu. 2014. Silencing of poly(ADP-ribose) polymerase-1 suppresses hyperstretch-induced expression of inflammatory cytokines in vitro. Acta Biochimica et Biophysica Sinica Shanghai 46: 556–564.CrossRefGoogle Scholar
  26. 26.
    Haseneen, N.A., G.G. Vaday, S. Zucker, and H.D. Foda. 2003. Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN. American Journal of Physiology - Lung Cellular and Molecular Physiology 284: L541–L547.CrossRefPubMedGoogle Scholar
  27. 27.
    Thomas, R.A., J.C. Norman, T.T. Huynh, B. Williams, S.J. Bolton, and A.J. Wardlaw. 2006. Mechanical stretch has contrasting effects on mediator release from bronchial epithelial cells, with a rho-kinase-dependent component to the mechanotransduction pathway. Respiratory Medicine 100: 1588–1597.CrossRefPubMedGoogle Scholar
  28. 28.
    Spiegel, A., S. Shivtiel, A. Kalinkovich, A. Ludin, N. Netzer, P. Goichberg, Y. Azaria, I. Resnick, I. Hardan, H. Ben-Hur, A. Nagler, M. Rubinstein, and T. Lapidot. 2007. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nature Immunology 8: 1123–1131.CrossRefPubMedGoogle Scholar
  29. 29.
    Reuter, S., H. Beckert, and C. Taube. 2016. Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases. Laboratory Investigation; A Journal of Technical Methods and Pathology 96: 177–185.CrossRefPubMedGoogle Scholar
  30. 30.
    Chen, C.L., H. Li, X.H. Xing, H.S. Guan, J.H. Zhang, and J.W. Zhao. 2015. Effect of TRPV1 gene mutation on bronchial asthma in children before and after treatment. Allergy and Asthma Proceedings 36: e29–e36.CrossRefPubMedGoogle Scholar
  31. 31.
    Ho, C.Y., C.K. Wong, F.W. Ko, C.H. Chan, A.S. Ho, D.S. Hui, and C.W. Lam. 2002. Apoptosis and B-cell lymphoma-2 of peripheral blood T lymphocytes and soluble fas in patients with allergic asthma. Chest 122: 1751–1758.CrossRefPubMedGoogle Scholar
  32. 32.
    Liu, Z., X. Liu, L. Sang, H. Liu, and Q. Xu. 2015. Boswellic acid attenuates asthma phenotypes by downregulation of GATA3 via pSTAT6 inhibition in a murine model of asthma. International Journal of Clinical and Experimental Pathology 8: 236–243.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Xiao, C., S.M. Puddicombe, S. Field, J. Haywood, V. Broughton-Head, I. Puxeddu, H.M. Haitchi, E. Vernon-Wilson, D. Sammut, N. Bedke, C. Cremin, J. Sones, R. Djukanovic, P.H. Howarth, J.E. Collins, S.T. Holgate, P. Monk, and D.E. Davies. 2011. Defective epithelial barrier function in asthma. The Journal of Allergy and Clinical Immunology 128(549–556): e541–e512.Google Scholar
  34. 34.
    Georas, S.N., and F. Rezaee. 2014. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. The Journal of Allergy and Clinical Immunology 134: 509–520.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Penberthy, K.K., I.J. Juncadella, and K.S. Ravichandran. 2014. Apoptosis and engulfment by bronchial epithelial cells. Implications for allergic airway inflammation. Annals of the American Thoracic Society 11(Suppl 5): S259–S262.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Copland, I.B., and M. Post. 2007. Stretch-activated signaling pathways responsible for early response gene expression in fetal lung epithelial cells. Journal of Cellular Physiology 210: 133–143.CrossRefPubMedGoogle Scholar
  37. 37.
    Uglietta, J.P., W.W. Woodruff, E.L. Effmann, and B.A. Carroll. 1989. Duplex Doppler ultrasound evaluation of calcified inferior vena cava thrombosis. Pediatric Radiology 19: 250–252.CrossRefPubMedGoogle Scholar
  38. 38.
    Xi, W., Y. Hu, Y. Liu, J. Zhang, L. Wang, Y. Lou, Z. Qu, J. Cui, G. Zhang, X. Liang, C. Ma, C. Gao, Y. Chen, and S. Liu. 2011. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Molecular Immunology 48: 1203–1208.CrossRefPubMedGoogle Scholar
  39. 39.
    Popa, C., M.G. Netea, P.L. van Riel, J.W. van der Meer, and A.F. Stalenhoef. 2007. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. Journal of Lipid Research 48: 751–762.CrossRefPubMedGoogle Scholar
  40. 40.
    Ying, S., B. O’Connor, J. Ratoff, Q. Meng, C. Fang, D. Cousins, G. Zhang, S. Gu, Z. Gao, B. Shamji, M.J. Edwards, T.H. Lee, and C.J. Corrigan. 2008. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. Journal of Immunology 181: 2790–2798.CrossRefGoogle Scholar
  41. 41.
    Biagini Myers, J.M., L.J. Martin, M.B. Kovacic, T.B. Mersha, H. He, V. Pilipenko, M.A. Lindsey, M.B. Ericksen, D.I. Bernstein, G.K. LeMasters, J.E. Lockey, and G.K. Khurana Hershey. 2014. Epistasis between serine protease inhibitor Kazal-type 5 (SPINK5) and thymic stromal lymphopoietin (TSLP) genes contributes to childhood asthma. The Journal of Allergy and Clinical Immunology 134(891–899): e893.Google Scholar
  42. 42.
    Wang, I.J., L.S. Wu, G.A. Lockett, and W.J. Karmaus. 2016. TSLP polymorphisms, allergen exposures, and the risk of atopic disorders in children. Annals of Allergy, Asthma, and Immunology 116(139–145): e131.Google Scholar
  43. 43.
    Han, Z., Junxu, and N. Zhong. 2003. Expression of matrix metalloproteinases MMP-9 within the airways in asthma. Respiratory Medicine 97: 563–567.CrossRefPubMedGoogle Scholar
  44. 44.
    Asai, K., H. Kanazawa, H. Kamoi, S. Shiraishi, K. Hirata, and J. Yoshikawa. 2003. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clinical and Experimental Allergy 33: 595–599.CrossRefPubMedGoogle Scholar
  45. 45.
    Neumann, J., K. Schaale, K. Farhat, T. Endermann, A.J. Ulmer, S. Ehlers, and N. Reiling. 2010. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosis-infected macrophages. FASEB journal: Official Publication of the Federation of American Societies for Experimental Biology 24: 4599–4612.CrossRefGoogle Scholar
  46. 46.
    Zhang, J., X. Wen, X.Y. Ren, Y.Q. Li, X.R. Tang, Y.Q. Wang, Q.M. He, X.J. Yang, Y. Sun, N. Liu, and J. Ma. 2016. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/beta-catenin signaling pathway. Journal of Experimental & Clinical Cancer Research: CR 35: 109.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.First Department of Respiratory MedicineXi’an Children’s HospitalXi’anChina
  2. 2.First Neonatal DepartmentXi’an Children’s HospitalXi’anChina

Personalised recommendations